About the Product
Life Pro Nutrition's Silymarin is a dietary supplement in VCAPS vegetable capsules formulated with dry extract of milk thistle seeds (Silybum marianum) standardized to 80% silymarin and 30% silybin, providing 333 mg of silymarin and 125 mg of silybin per capsule (416.5 mg of total extract). Silymarin is a complex of flavonolignans extracted from milk thistle seeds, with centuries of use in traditional European and Mediterranean medicine for liver health support, and one of the herbal supplements with the largest base of clinical evidence for protecting and supporting liver function. Silybin (or silybinin) is the most abundant and most active flavonolignan in silymarin, and is responsible for its main hepatoprotective effects. 1 capsule 2 times/day with main meals = 833 mg of silymarin/day. 120 capsules (60 days of treatment). Vegan.
Benefits
Silymarin and silybin: the flavonolignan complex with the largest base of clinical evidence in herbal hepatoprotection:
Milk thistle (Silybum marianum, Asteraceae family) is a biennial herbaceous plant native to the Mediterranean region, with purple flowers and distinctive white-marked leaves (which gave rise to the popular name "milk thistle" in English, as the white veins were historically attributed to the milk of the Virgin Mary). Milk thistle seeds contain silymarin, a complex of flavonolignans that includes several compounds: silybin A and B (the most abundant, collectively called silybinin, representing 50 to 70% of the total silymarin), isosilybin A and B, silychristin, isosilychristin, and silydianin. These flavonolignans are hybrid compounds between flavonoids (polyphenols) and lignans (phenylpropanoid compounds), with documented antioxidant, anti-inflammatory, and hepatoprotective properties in both preclinical studies and clinical trials. The Life Pro formula's standardization to 80% silymarin and 30% silybin ensures a high and consistent content of active flavonolignans, superior to most milk thistle extracts available on the market (which are typically standardized to 70% silymarin with variable and often undeclared silybin content).
Hepatoprotection and liver regeneration: the documented mechanisms of action of silymarin:
Silymarin exerts hepatoprotective effects via multiple complementary molecular mechanisms. Firstly, it has direct antioxidant activity: flavonolignans scavenge free radicals and reactive oxygen species (ROS) produced in the hepatic metabolism of xenobiotics, protecting hepatocyte membranes and intracellular proteins from oxidative damage. In addition to direct antioxidant action, silymarin stimulates endogenous glutathione (GSH) synthesis in the liver via activation of the Nrf2 transcription factor (nuclear factor erythroid 2-related factor 2), which regulates the expression of phase II antioxidant genes (including γ-glutamylcysteine synthetase, the rate-limiting enzyme for GSH synthesis), thereby increasing hepatic antioxidant capacity in a sustained manner. Secondly, silymarin inhibits the lipid peroxidation of hepatocyte membranes: the phospholipids of cell membranes are particularly susceptible to oxidation by free radicals (especially in contexts of hepatic toxicity from alcohol, paracetamol, aflatoxins, or heavy metals), and silymarin breaks the lipid peroxidation chain, protecting the structural integrity of cell membranes. Thirdly, silybin inhibits the uptake and intracellular accumulation of certain hepatotoxins (such as amatoxins from the Amanita phalloides mushroom, the poison thistle toxin, and heavy metals) by competing with organic anion transporters (OAT/OATP) on the basolateral membrane of the hepatocyte, reducing the intracellular toxic load. Fourthly, silymarin stimulates ribosomal RNA (rRNA) synthesis and, consequently, protein synthesis in hepatocytes, accelerating the regeneration of damaged liver tissue.
Regulation of liver enzymes (ALT, AST, GGT): the most commonly used marker in clinical settings:
Liver transaminases (alanine aminotransferase, ALT, and aspartate aminotransferase, AST) and gamma-glutamyltransferase (GGT) are enzymes that, when elevated in plasma, indicate liver injury or dysfunction (as their elevation results from leakage into the bloodstream due to hepatocyte membrane damage). Multiple clinical trials with silymarin have documented significant reductions in ALT, AST, and GGT values in patients with chronic viral hepatitis (hepatitis B and C), alcoholic hepatitis, non-alcoholic fatty liver disease (NAFLD/NASH), and drug-induced liver injury compared to placebo. The meta-analysis by Zhong et al. (2017) analyzed 17 randomized clinical trials with silymarin in patients with chronic hepatitis C and documented a significant reduction in ALT with silymarin compared to placebo. The meta-analysis by Hadi et al. (2018), published in Scientific Reports with data from patients with type 2 diabetes, documented significant reductions in ALT and AST with silymarin compared to placebo, suggesting relevant hepatoprotective effects even in metabolic contexts beyond direct liver injury.
Systemic antioxidant effect and support for metabolic control:
In addition to liver-specific effects, silymarin has systemic antioxidant and anti-inflammatory effects with metabolic relevance. The review by Gillessen & Schmidt (2020) documented that silymarin can improve insulin sensitivity and reduce fasting glucose in patients with insulin resistance and type 2 diabetes, possibly via a reduction in mitochondrial oxidative stress in hepatocytes and skeletal muscles (which contributes to insulin receptor dysfunction via activation of stress kinases such as JNK and IKKβ). Silymarin may also have modest effects on the lipid profile (reduction of LDL-cholesterol and triglycerides), possibly via improved liver function and regulation of lipoprotein synthesis in the liver.
Relevance for athletes and supplement users with high hepatic metabolic load:
The liver is the primary organ for xenobiotic metabolism, and athletes who use multiple supplements (especially in high volumes and frequencies), who consume moderate amounts of alcohol socially, or who are exposed to high training volumes with the consequent increase in ROS production and protein catabolism (with an increased load of nitrogenous metabolites that the liver processes via the urea cycle), have a higher than average hepatic metabolic load. Silymarin is specifically mentioned as a "star supplement" in liver health products such as Life Pro's Hepa Pro, and is recommended by the brand for this user profile.
Usage
Recommended dose: Take 1 capsule twice/day, with main meals (breakfast and dinner, or lunch and dinner). Co-ingestion with food improves silymarin absorption (which is lipophilic and benefits from co-absorption with dietary fat) and reduces the risk of gastrointestinal discomfort. Continued treatment for at least 4 to 6 weeks for evaluation of effects on liver function (effects on liver markers such as ALT/AST are gradual and cumulative, not immediate). 120 capsules = 60 days of treatment with the recommended dose.
